Impact BioMedical (IBO): שווי שוק להכנסות

Impact BioMedical Inc (IBO) is developing a biomedical holding company based on the implementation of the 3F repellent and the sale of patents. Unique plant-based formulas that block viruses provide moderate pricing power. P/S levels on the chart demonstrate the market valuation of revenue, where the 1016.10 indicator determines this level. The company's strategy is based on licensing intellectual property to bypass direct price competition.

Impact BioMedical Inc (IBO) is developing high-tech R&D capabilities in biomedicine and antiviral solutions, making revenue the key basis for assessing its scalability. The relationship between market capitalization and sales volume, represented by the price-to-sales ratio, reveals deviations of market value from the average, signaling asset overvaluation when the metric exceeds standard deviation boundaries and a probable reversion to the median.